返回
Telix Pharmaceuticals Ltd（TLPPF）价格
TLPPF 股价走势图
TLPPF 收益
Telix Pharmaceuticals Ltd
$7.72
8.73%
$0.62
收盘价：Jan 16, 16:00:00 GMT-5
$7.72
0%
$0
盘后：Jan 16, 20:00:00 GMT-5
最新收益结果： Q2 '25
报告： 2025-08-21
历史收益
季度性
年度
EPS
收入
Earnings FAQ
TLPPF 最近的每股收益与预期相比如何？
Telix Pharmaceuticals Ltd TLPPF 上一季度的收入表现如何？
Telix Pharmaceuticals Ltd 的收入预期是多少？
Telix Pharmaceuticals Ltd 的盈利质量评分是多少？
Telix Pharmaceuticals Ltd 何时发布财报？
Telix Pharmaceuticals Ltd 的预期收益是多少？
Telix Pharmaceuticals Ltd 是否超出收益预期？
关键数据
前收盘价
$7.1
开盘价
$7.4
当日区间
$7.4 - $7.72
52周范围
$6.95 - $24.85
交易量
5.2K
平均成交量
2.4K
每股收益（TTM）
0.02
股息收益率
--
市值
$2.5B
什么是 TLPPF？
Telix Pharmaceuticals Limited.engages in the development and commercialization of several clinical-stage oncology assets. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-11-15. The company is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.